Page last updated: 2024-08-21

ethyl gallate and Shock, Cardiogenic

ethyl gallate has been researched along with Shock, Cardiogenic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, ZQ; Gotes, J; Jacobs, H; Kasian, K; Mink, SN1
Alston, TA; Wang, J1

Other Studies

2 other study(ies) available for ethyl gallate and Shock, Cardiogenic

ArticleYear
Benefits of ethyl gallate versus norepinephrine in the treatment of cardiovascular collapse in Pseudomonas aeruginosa septic shock in dogs.
    Critical care medicine, 2012, Volume: 40, Issue:2

    Topics: Analysis of Variance; Animals; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Gallic Acid; Norepinephrine; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Risk Assessment; Shock, Cardiogenic; Shock, Septic; Survival Rate; Treatment Outcome

2012
Gallic treatment is galling to Pseudomonas.
    Critical care medicine, 2012, Volume: 40, Issue:2

    Topics: Animals; Gallic Acid; Norepinephrine; Pseudomonas aeruginosa; Pseudomonas Infections; Shock, Cardiogenic; Shock, Septic

2012